Loading...
Market
What will be the total value of leveraged buyouts in the health sector in 2024?
2
Resolution / Starting Odds
Less than €50 billion • 25%
€50 billion to €75 billion • 25%
€75 billion to €100 billion • 25%
More than €100 billion • 25%
Financial reports, industry analysis publications
Story
Sanofi Nears €15.5 Billion Sale of 50% Stake in Opella to CD&R
Oct 11, 2024, 04:44 AM
Sanofi is nearing a significant deal to sell a 50% controlling stake in its consumer health unit, Opella, to Clayton Dubilier & Rice (CD&R). The transaction, valued at approximately €15.5 billion ($16 billion), is poised to be one of the largest deals of the year. CD&R has reportedly outbid rivals, including a consortium led by PAI Partners, to secure this acquisition. The sale, estimated at €15 billion, is seen as a critical health check for mega leveraged buyouts (LBOs) and underscores the growing interest in the consumer health sector.
View original story
Similar markets
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $150 million • 25%
More than $150 million • 25%
Less than $100M • 33%
$100M to $200M • 33%
More than $200M • 33%
Above $600 billion • 25%
$550 billion to $600 billion • 25%
$500 billion to $550 billion • 25%
Below $500 billion • 25%
Under $1 billion • 25%
$1-2 billion • 25%
$2-3 billion • 25%
Over $3 billion • 25%
Below $7.5 billion • 25%
$7.5 billion to $8 billion • 25%
$8 billion to $8.5 billion • 25%
Above $8.5 billion • 25%
Below 3.0x • 25%
3.0x - 3.25x • 25%
3.26x - 3.5x • 25%
Above 3.5x • 25%
Less than $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
$2 billion to $2.5 billion • 25%
More than $2.5 billion • 25%
Less than $10 billion • 25%
$10 billion to $15 billion • 25%
$15 billion to $20 billion • 25%
More than $20 billion • 25%
Less than $20M • 25%
$20M to $40M • 25%
$40M to $60M • 25%
More than $60M • 25%
Yes • 50%
No • 50%
Less than $50M • 25%
$50M to $100M • 25%
$100M to $200M • 25%
More than $200M • 25%